$80.95
0.190.24%
In chiusura: -
$80.95
N/A
After hour: 4:00 PM EDT
Monopar Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Monopar Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
MNPR | Monopar Therapeutics | -$0.37 | -$0.43 | — | — | $0.00 | — | — | — | 11/21/2025 | |
MNPR | Monopar Therapeutics | -$0.49 | -$0.48 | -$0.35 | 27.08% | $0.00 | — | $0.00 | — | 08/12/2025 | |
MNPR | Monopar Therapeutics | -$0.51 | -$0.57 | -$0.38 | 33.33% | $0.00 | — | $0.00 | — | 05/13/2025 | |
MNPR | Monopar Therapeutics | -$0.60 | -$0.42 | -$2.23 | -430.95% | $0.00 | — | $0.00 | — | 03/31/2025 | |
MNPR | Monopar Therapeutics | -$0.69 | -$0.48 | -$0.37 | 22.92% | $0.00 | — | $0.00 | — | 11/08/2024 | |
MNPR | Monopar Therapeutics | -$0.80 | -$0.45 | -$0.50 | -11.11% | $0.00 | — | $0.00 | — | 08/09/2024 | |
MNPR | Monopar Therapeutics | -$0.95 | -$0.70 | -$0.50 | 28.57% | $0.00 | — | $0.00 | — | 05/09/2024 | |
MNPR | Monopar Therapeutics | -$1.10 | -$0.75 | -$0.60 | 20.00% | $0.00 | — | $0.00 | — | 03/28/2024 | |
MNPR | Monopar Therapeutics | -$0.95 | -$0.85 | -$0.70 | 17.65% | $0.00 | — | $0.00 | — | 11/09/2023 | |
MNPR | Monopar Therapeutics | -$1.10 | -$0.90 | -$0.80 | 11.11% | $0.00 | — | $0.00 | — | 08/10/2023 | |
MNPR | Monopar Therapeutics | -$0.95 | -$1.10 | -$0.95 | 13.64% | $0.00 | — | $0.00 | — | 05/11/2023 | |
MNPR | Monopar Therapeutics | -$1.05 | -$1.00 | -$1.10 | -10.00% | $0.00 | — | $0.00 | — | 03/23/2023 | |
MNPR | Monopar Therapeutics | -$1.00 | — | -$0.95 | — | $0.00 | — | $0.00 | — | 11/10/2022 | |
MNPR | Monopar Therapeutics | -$0.85 | -$1.05 | -$1.10 | -4.76% | $0.00 | — | $0.00 | — | 08/11/2022 | |
MNPR | Monopar Therapeutics | -$0.80 | -$1.10 | -$0.95 | 13.64% | $0.00 | — | $0.00 | — | 05/12/2022 | |
MNPR | Monopar Therapeutics | -$0.95 | -$0.95 | -$1.05 | -10.53% | $0.00 | — | $0.00 | — | 03/24/2022 | |
MNPR | Monopar Therapeutics | -$0.75 | -$1.05 | -$1.00 | 4.76% | $0.00 | — | $0.00 | — | 11/12/2021 | |
MNPR | Monopar Therapeutics | -$0.70 | -$0.95 | -$0.85 | 10.53% | $0.00 | — | $0.00 | — | 08/12/2021 | |
MNPR | Monopar Therapeutics | -$0.50 | -$1.10 | -$0.80 | 27.27% | $0.00 | — | $0.00 | — | 05/13/2021 | |
MNPR | Monopar Therapeutics | -$0.65 | — | -$0.95 | — | $0.00 | — | $0.00 | — | 03/25/2021 | |
MNPR | Monopar Therapeutics | -$0.40 | — | -$0.75 | — | — | — | $0.00 | — | 11/12/2020 |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-12 | $-0.35 | $-0.48 | 27.1 % |
| Q1 | 2025-05-13 | $-0.38 | $-0.57 | 33.3 % |
| Q4 | 2025-03-31 | $-2.23 | $-0.42 | -430.9 % |
| Q3 | 2024-11-08 | $-0.37 | $-0.48 | 22.9 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
Si prevede che Monopar Therapeutics (MNPR) fornisca risultati il novembre 21, 2025. Gli ultimi risultati sono stati pubblicati il agosto 12, 2025 per il Q2.
L'EPS effettivo era $-0.35, che superato la stima di $-0.48.
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.